Isolators offer a safety and economic advantage for next-generation regenerative medicine products.
Mamoru Kokubo
Advertisement
Mamoru Kokubo, PhD, is general manager, microbial control department at RP System Division, Shibuya Kogyo Co., Ltd.
Articles by Mamoru Kokubo
Advertisement
Latest Updated Articles
Aseptic Processing for Cytotherapy, Regenerative Medicine, and Tissue-Engineered ProductsPublished: October 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
